AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04816071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Essential amino acids
Description: Dietary Supplement
Study NCT04816071 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Control
Study NCT05308771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VPC syringe
Description: Use of the visual pressure control syringe for epidural space detection
Study NCT05876845 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined pre-, pro-, and post-biotic supplement
Description: Participants will take 2 capsules daily with water, with their first meal of the day.
Study NCT06386679 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: allogenic amniotic fluid mesenchymal stem cell
Description: Intra-articular AFCC injection will be given for single knee for each patient in single dose, 20 million of AFCC in each dose
Study NCT05353062 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemostatic therapy
Description: Bipolar hemostatic forceps
Study NCT05353062 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic therapy with hemoclip +/- injection of epinephrine solution
Description: Endoscopic therapy with hemoclip +/- injection of epinephrine solution
Study NCT06061029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Yoga- and Mindfulness-Based Psychoeducation Program
Description: A unique mindfulness psychoeducation program incorporating features of Hatha yoga and mindfulness-based cognitive therapy, plus the main concepts of self-compassion
Study NCT06365983 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective Tissue with Free Gingival Graft
Description: The de-epithelialized free gingival grafting will begin with two horizontal incisions, 1.0 to 1.5 mm apical to the margin of the soft tissue of the adjacent teeth and two vertical incisions to delimit the area to be grafted. Along the coronal horizontal incision, the blade will be oriented almost perpendicular to the bone surface, and once an adequate thickness of soft tissue is obtained, it will be rotated to become almost parallel to the external surface of the palate. The graft thickness will be maintained uniform and the wound will be protected with absorbable collagen sponge derived from swine (Spongostan; Ethicon, Somerville, USA) and maintained with compressive sutures with non-absorbable 5-0 monofilament thread (Microsuture, São Paulo), anchored to the soft tissue apical to the area of the palatal wound. Immediately after suture completion, drops of high viscosity cyanoacrylate adhesive (PeriAcryl 90 HV; Glustitch, Delta, Canada) will be applied.
Study NCT06365983 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Connective Tissue with Linear Incision
Description: The linear technique (Lorenzana ER, Allen EP 2000) will begin with a horizontal incision 2 mm apical to the gingival margin, perpendicular to the palate, which is deepened to the bone crest. Next, a second incision is made to divide the flap and expose the connective tissue bed. The thickness of the outer portion of the flap should be at least 1 mm, with uniformity throughout its extension to reduce the risk of epithelial tissue necrosis. Subsequently, internal lateral incisions (mesial and distal) and the base incision will be made, connecting the vertical incisions to delineate horizontal and vertical boundaries. Immediately after graft removal, an absorbable hemostatic collagen sponge derived from swine (Spongostan; Ethicon, Somerville, USA) will be placed and sutured using non-absorbable 5-0 monofilament thread (Microsuture, São Paulo).Immediately after suturing is completed, drops of high viscosity cyanoacrylate adhesive (PeriAcryl 90 HV; Glustitch, Delta, Canada) will be applied.
Study NCT05529329 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: overlay
Description: Lithium Disilicate partial coverage of hypo-mineralized defected enamel
Study NCT05529329 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: overlay
Description: Lithium Disilicate partial coverage of hypo-mineralized defected enamel
Study NCT06027021 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 18F-Fluoromisonidazole PET
Description: Imaging of hypoxia before radioembolization with 18F-Fluoromisonidazole PET.
Study NCT06224933 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Augmented Reality System
Description: Subjects will undergo image guided needle aspiration, injection, or biopsy facilitated by the Augmented Reality system. The Augmented Reality guidance system will be operated by the interventional radiologist in the MRI suite.
Study NCT04644614 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Stimulation - Armchair type
Description: MS and Sham MS will be applied two days a week, 20 minutes a day, for 8 weeks, a total of 16 sessions.
Study NCT04644614 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Magnetic Stimulation - Armchair type
Description: MS and Sham MS will be applied two days a week, 20 minutes a day, for 8 weeks, a total of 16 sessions.
Study NCT05658094 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exosome
Description: Each patients will receive 4 injection with an interval of 14 days during two months
Study NCT05311358 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The engineer-built system, video-game based Kinect sensor
Description: There are 3 computer games using Kinect sensor to detect movement of trunk and upper extremities of the children.
Study NCT05768815 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breaking the Cycle Program
Description: BTC is a prevention and early intervention program in Toronto, Canada, serving substance-using pregnant and/or parenting women with children under six years of age. Established by the Canadian Mothercraft Society in 1995, BTC is funded by the Community Action Program for Children and the Canadian Prenatal Nutrition Program through the Public Health Agency of Canada. BTC provides three program components that act synergistically: a) individualized services for mothers, b) individualized services for children, and c) relational interventions that enhance the mother-child relationship and promote infant mental health. Coordinated supports are offered through formal partnerships across service sectors. In 2004, BTC was recognized by the United Nations as an exemplary program serving pregnant and parenting women with substance use problems, and their young children.
Study NCT05768815 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Maxxine Wright Program
Description: Founded in 2005 and located in Surrey, British Columbia, the Maxxine Wright Community Health Centre (MWCHC) supports women who are pregnant and/or have young children and are impacted by substance use and/or violence. Women do not need to have children in their care to receive services. The program is funded and operated by the Fraser Health Authority, with additional in-kind support from the BC Ministry for Children and Family Development and the BC Ministry of Social Development and Poverty Reduction. MW addresses maternal substance use and exposure to violence through women-centered, trauma-informed, culturally grounded, and interdisciplinary approaches. Primary services offered include addiction counselling, primary health care, and group therapy to address interpersonal violence. Within MW, child-focused services are limited to primary health (e.g., well baby checks, childcare).
Study NCT04959968 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eye patch and earplug
Description: The use of eye patch and ear plugs in post-operative intensive care in craniotomy cases.
Study NCT05804175 — intervention group
Intervention type: DEVICE
Intervention: Linshom Continuous Predictive Respiratory Monitoring
Description: Observational study. Monitoring of Linshom, pulse oximetry and capnography data with comparison to current standard of care.
Study NCT04930848 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Euphorbia hirta (Dudhiya)
Description: Duration of the intervention was 2 consecutive weeks or 14 days. In each evening, one teaspoon full (3gm) powder should be mixed with two cups of water and boiled. When it becomes half(one cup), have to add one teaspoon of sugar and drink it as tea.
Study NCT04930848 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PBO(Combined powder of Terminalia arjuna and Terminalia bellerica)
Description: Duration of the intervention was 2 consecutive weeks or 14 days. In each evening, one teaspoon full (3gm) powder should be mixed with two cups of water and boiled. When it becomes half(one cup), have to add one teaspoon of sugar and drink it as tea.
Study NCT05468437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telenutrition
Description: Nutrition education and individualized nutrition counseling will be done with a Registered Dietitian via video-conferencing with iPad FaceTime, which is aimed to decrease the risk of complications like obesity, high cholesterol, or diabetes, and explore associations between bowel and bladder function and nutrition. The telenutrition counseling consists of 6 sessions that are scheduled approximately 2 weeks apart. The first session will last approximately 1 hour, while sessions 2-6 will last approximately 30mins. During these sessions, the Registered Dietitian will share nutrition education tailored towards people with SCI. You will be involved in developing personal nutrition goals and the dietitian will help you address barriers to meeting your goals and provide individualized feedback to improve and maintain your nutrition. Telenutrition appointments will maintain privacy and will not be recorded.
Study NCT05945277 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Critical Time Intervention - Peer Support
Description: CTI-PS is a time-limited, 9-month long intervention, provided at the critical time when a person is discharged from an inpatient psychiatric treatment facility.
Study NCT05561725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone postoperative
Description: Patients randomized to the dexamethasone cohort will be administered 8 mg of dexamethasone with 3 additional (8mg doses) administered at 8-hour intervals following surgery for a total of 4 doses.~All patients will undergo a standardized post-operative pathway in the hospital following surgery that has been utilized for all AIS patients at our center since 2014.
Study NCT05561725 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Patients in the control group will receive one 8mg dose of dexamethasone intraoperatively as per standard of care anesthesia protocols. No sham medication will be utilized for control subjects.~All patients will undergo a standardized post-operative pathway in the hospital following surgery that has been utilized for all AIS patients at our center since 2014.
Study NCT05295927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPI-7386
Description: EPI-7386 will be administered orally once daily.
Study NCT05946005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: honey
Description: Tresno Joyo honey applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: MD252109001219
Study NCT05946005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine
Description: Dolones cream applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: DKL0922246629AI
Study NCT05946005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: povidone-iodine
Description: Betadine cream applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: PKD20501710037
Study NCT05946005 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: control groups
Description: no intervention is given
Study NCT05295927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate
Description: Abiraterone Acetate will be administered orally once daily.
Study NCT05295927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone or Prednisolone
Description: Prednisone or Prednisolone will be administered orally twice daily.
Study NCT05295927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide
Description: Apalutamide will be administered orally once daily.
Study NCT05078164 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bridging the Gap (BTG)
Description: Bridging the Gap: Bridging the Gap is a hybrid model for violence prevention which integrates a hospital-based brief violence intervention (BVI) delivered to the patient while in hospital with a wrap-around community case management prevention strategy.~Firearm Counseling Program: The firearm counseling program was developed to be administered in the hospital alongside the 6-step intervention program, as well as in the patient's home after hospital discharge. The firearm safety counseling program includes 3 components aimed at understanding patient risk, reducing firearm-related violence risk-factors, and helping patients increase firearm safety practices.
Study NCT06167993 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Complex Decongestive Physiotherapy
Description: Complex Decongestive Physiotherapy; It consists of manual therapy, skin care, compression therapy and therapeutic exercise.
Study NCT06167993 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex Decongestive Physiotherapy
Description: Complex Decongestive Physiotherapy; It consists of manual therapy, skin care, compression therapy and therapeutic exercise.
Study NCT05632549 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Group 1 (n=22) which will receive traditional therapy plus placebo capsule twice daily for 3 months.
Study NCT05632549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-Carnitine 500Mg Oral Tablet
Description: Group 2 (n=22) which will receive traditional therapy plus L-carnitine capsules (500 mg twice daily) for 3 months.
Study NCT05632549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biotin Capsules
Description: Group 3 (n=22) which will receive traditional therapy plus Biotin capsules (5 mg twice daily) for 3 months.
Study NCT05708716 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified ketogenic diet using an exogenous ketogenic formula
Description: Participants will follow a modified ketogenic diet consuming a daily exogenous ketogenic meal replacement formula while limiting their carbohydrate intake for 12 weeks.
Study NCT05708716 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online cognitive training
Description: Participants will complete a daily session of 5 online cognitive training tasks for 12 weeks.
Study NCT05708716 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online cognitive training
Description: Participants will complete a daily session of 5 online cognitive training tasks for 12 weeks.
Study NCT04663971 — intervention group
Intervention type: PROCEDURE
Intervention: Any surgery
Description: Any surgical procedures performed for inflammatory bowel diseases
Study NCT04663971 — intervention group
Intervention type: PROCEDURE
Intervention: Any medical treatment
Description: Any treatment (including non-surgical) performed for inflammatory bowel diseases
Study NCT05687513 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yisui granule
Description: Yisui granule
Study NCT05687513 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT05492981 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced (intervention) education
Description: See arm description
Study NCT05024136 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Limon essential oil aromatherapy
Description: Subjects receive three times 30 mins aromatherapy of Limon essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV（heart rate variability）; c. LF（0.04-0.15 Hz）and HF（0.15-0.4 Hz）were measured every week. PSQI（Pittsburgh sleep quality index）and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.
Study NCT05024136 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vetiver essential oil aromatherapy
Description: Subjects receive three times 30 mins aromatherapy of vetiver essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV（heart rate variability）; c. LF（0.04-0.15 Hz）and HF（0.15-0.4 Hz）were measured every week. PSQI（Pittsburgh sleep quality index）and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.
Study NCT05271331 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ESP block with saline
Description: Bilateral ultrasound guided injection of saline in the erector spinae plane (below erector spinae plane muscle group and above the transverse process of the vertebra)
Study NCT05271331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Wound infiltration with saline
Description: Blinded injection of saline in the skin, subcutaneous tissue and muscles at the site of surgical incision
Study NCT05271331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ESP block with local anesthetic
Description: Bilateral ultrasound guided injection of local anesthetic (ropivacaine 0.35%, 40ml) in the erector spinae plane (below erector spinae plane muscle group and above the tranverse process of the vertebra)
Study NCT05271331 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Wound infiltration with local anesthetic
Description: Blinded injection of local anestetic (ropivacaine 0.35%, 40ml) in the skin, subcutaneous tissue and muscles at the site of surgical incision.
Study NCT06536556 — intervention group
Intervention type: OTHER
Intervention: First Assessment
Description: pre-treatment assessment
Study NCT06536556 — intervention group
Intervention type: OTHER
Intervention: Second Assessment
Description: 4 days post-treatment assessment
Study NCT05836688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal-Focused Emotion-Regulation Therapy (GET)
Description: Patients will be asked to identify value-derived goals (i.e., goals for the most important domains of one's life) and ones sufficiently important to sustain movement toward them in the short-term future. Patients will discuss their goal possibilities, providing a forum to ensure that goals are manageable and consistent with identified values. Patients will learn strategies to refine their goals (e.g., approaching goals rather than avoiding obstacles, defining markers of progress), generate pathways to goals, and address potential obstacles and blockages. The overall goal is to enhance self-regulation through improved goal navigation skills, improved sense of meaning and purpose, and better ability to regulate specific emotional responses.
Study NCT05836688 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individual Supportive Listening
Description: ISL sessions will be matched in terms of time and attention. Supportive therapy will be non-directive and will primarily reinforce a patient's ability to manage stressors through attentively listening and encouraging expression of thoughts and feelings, assisting the individual to gain a greater understanding of their situation and alternatives, and helping to buttress the individual's self-esteem and resilience. This will be delivered in the same manner as GET (individually) and is a common, non-directive control method in intervention research.
Study NCT05699382 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: practiced mindfulness through the application for 6 weeks
Description: Physicians working at a tertiary hospital were recruited and randomly divided into two groups, a study group (SG) in which participants practiced mindfulness through the application for 6 weeks
Study NCT05454696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Patients in the exercise group will participate in online clinical pilates exercise sessions under the supervision of a physiotherapist twice a week. The exercises will be done via the Zoom application and will continue for 6 weeks. The exercise program will last one hour with a warm-up and cool-down period. The exercises will be done by adhering to the basic principles of clinical pilates. The exercise program includes mat exercises that provide general body strengthening and stretching. Progression will be provided according to the health status of the patients and their compliance with exercise. The intensity of exercise will be planned as medium according to the Rating of perceived exertion (RPE) Scale.
Study NCT05454696 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: online physical activity counselling
Description: CG will receive online physical activity counselling by a physiotherapist only once. The importance of physical activity after surgery and the points to be considered during physical activity will be explained to the patients.
Study NCT06677957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Digoxin will be administered together with Rosuvastatin as a drug cocktail as specified for the respective period
Study NCT06677957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Divarasib
Description: Divarasib will be administered in combination with Digoxin and Rosuvastatin as specified for the respective period
Study NCT06677957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin will be administered together with Digoxin as a drug cocktail as specified for the respective period